A Flagship VentureLabs Company

BG Medicine, Inc.

610 North Lincoln Street

Waltham, MA  02451

Tel: 781.890.1199


Leadership:
Paul Sohmer, M.D.
President & CEO


Website:
www.bg-medicine.com

BG Medicine, Inc.

Flagship Partners:  Noubar Afeyan
Initial Investment: 
2000
Status: 
Public

BG Medicine (NASDAQ: BGMD) is a publicly traded developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

Noubar Afeyan is a Founder and serves on the Board of Directors and Stéphane Bancel is Executive Chairman of the Board.